146 related articles for article (PubMed ID: 2936706)
1. In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.
Davies GS; Cohen J
J Antimicrob Chemother; 1985 Dec; 16(6):713-7. PubMed ID: 2936706
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients.
Klinger JD; Aronoff SC
J Antimicrob Chemother; 1985 Jun; 15(6):679-84. PubMed ID: 3161856
[TBL] [Abstract][Full Text] [Related]
3. Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae.
Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
Infection; 1983; 11(6):326-8. PubMed ID: 6421743
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa.
Bustamante CI; Wharton RC; Wade JC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1814-5. PubMed ID: 2126693
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
Yasmin F; Akhtar N; Hameed A
Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa.
Haller I
Arzneimittelforschung; 1986 Feb; 36(2):226-9. PubMed ID: 2938593
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ciprofloxacin, azthreonam and ceftazidime against Serratia marcescens and Pseudomonas aeruginosa.
Righter J
Eur J Clin Microbiol; 1984 Aug; 3(4):368-9. PubMed ID: 6436021
[No Abstract] [Full Text] [Related]
9. Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Chalkley LJ; Koornhof HJ
Antimicrob Agents Chemother; 1985 Aug; 28(2):331-42. PubMed ID: 2939797
[TBL] [Abstract][Full Text] [Related]
10. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
[TBL] [Abstract][Full Text] [Related]
11. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
13. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
Kocazeybek B; Arabaci U; Erentürk S; Akdur H
Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
[TBL] [Abstract][Full Text] [Related]
16. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa.
Lang BJ; Aaron SD; Ferris W; Hebert PC; MacDonald NE
Am J Respir Crit Care Med; 2000 Dec; 162(6):2241-5. PubMed ID: 11112146
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
Thompson KD; O'Keefe JP; Tatarowicz WA
Antimicrob Agents Chemother; 1984 Aug; 26(2):275-6. PubMed ID: 6435518
[TBL] [Abstract][Full Text] [Related]
18. The comparative in-vitro activity of pefloxacin.
King A; Phillips I
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
[TBL] [Abstract][Full Text] [Related]
19. Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents.
Louie A; Baltch AL; Ritz WJ; Smith RP
J Antimicrob Chemother; 1991 Jun; 27(6):793-9. PubMed ID: 1657857
[TBL] [Abstract][Full Text] [Related]
20. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]